Q2 2023 · 13F-HR
Carlyle Group Inc. (CG, CGABL)holdings as filed
Filed 2023-08-04 · accession 0000898432-23-000571
$2.81B
Reported value
26
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 219798105 | QDEL | Quidelortho Corp | $1.03B | 36.8% | 12,460,183 | Common | SHARED |
| 98980F104 | GTM | ZoomInfo Technologies Inc | $930.9M | 33.2% | 36,662,469 | Common | SHARED |
| 55306N104 | MKSI | MKS Instrs Inc | $376.5M | 13.4% | 3,482,732 | Common | SHARED |
| G9440D103 | — | Vitru Ltd | $100.1M | 3.57% | 6,246,471 | Common | SHARED |
| 925050106 | VRNA | Verona Pharma Plc | $51.9M | 1.85% | 2,457,500 | Common | SHARED |
| 71722W107 | PHAT | Phathom Pharmaceuticals Inc | $50.1M | 1.78% | 3,496,808 | Common | SHARED |
| 374275105 | GETY | Getty Images Holdings Inc | $48.7M | 1.73% | 9,976,300 | Common | SHARED |
| 36165L108 | GDS | GDS Hldgs Ltd | $44.8M | 1.59% | 4,072,624 | Common | SHARED |
| 92337R101 | VERA | Vera Therapeutics Inc | $38.8M | 1.38% | 2,416,837 | Common | SHARED |
| 43157M102 | — | Hillevax Inc | $31.5M | 1.12% | 1,838,486 | Common | SHARED |
| 75974E103 | — | Reneo Pharmaceuticals Inc | $17.7M | 0.63% | 2,698,957 | Common | SHARED |
| 46187W107 | INVH | Invitation Homes Inc | $16.4M | 0.59% | 477,500 | Common | SHARED |
| 78413P101 | SMHI | Seacor Marine Hldgs Inc | $15.0M | 0.54% | 1,314,164 | Common | SHARED |
| 471871103 | — | Jasper Therapeutics Inc | $11.8M | 0.42% | 8,761,891 | Common | SHARED |
| 229663109 | CUBE | CubeSmart | $9.8M | 0.35% | 220,500 | Common | SHARED |
| 85209E109 | — | Spruce Biosciences Inc | $6.2M | 0.22% | 2,896,518 | Common | SHARED |
| 007002108 | TORCEUR | Adicet Bio Inc | $5.1M | 0.18% | 2,115,385 | Common | SHARED |
| 834203309 | SLNO | Soleno Therapeutics Inc | $5.1M | 0.18% | 1,201,506 | Common | SHARED |
| 83193E102 | EM | Smart Sh Global Ltd | $4.7M | 0.17% | 4,810,209 | Common | SHARED |
| 28202V108 | — | Effector Therapeutics Inc | $4.0M | 0.14% | 4,822,114 | Common | SHARED |
| 67022C106 | — | Nucana Plc | $2.6M | 0.09% | 3,333,333 | Common | SHARED |
| 699374302 | — | Paratek Pharmaceuticals Inc | $2.3M | 0.08% | 1,041,131 | Common | SHARED |
| 30205M200 | XCUREUR | Exicure Inc | $368,943 | 0.01% | 281,636 | Common | SHARED |
| 68276W400 | — | Meta Data Limited | $336,408 | 0.01% | 314,400 | Common | SHARED |
| 00773J103 | — | Aeglea Biotherapeutics Inc | $108,225 | 0.00% | 240,500 | Common | SHARED |
| 608550109 | — | Molecular Templates Inc | $92,000 | 0.00% | 200,000 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.